David Nevins is co-publisher of The Fulcrum and co-founder and board chairman of the Bridge Alliance Education Fund.

Lawmakers say middlemen in the prescription drug pipeline are limiting access to medications. It’s gotten the attention of ...

Donald Trump held a reception for Republican member of Congress at the White House last month. During his remarks, Trump vowed to reduce drug prices by more than 1000%, a physically impossible goal ...

Three years after President Joe Biden signed the Inflation Reduction Act, the Trump administration has significantly reduced ...

The average monthly premium for a stand-alone Part D drug plan dropped 9%, from $43 last year to $39 this year, according to ...

Yet as UnitedHealth's stock declined, Buffett's Berkshire Hathaway Inc. (BRK.B) (BRK.A) stepped in and bought 5.04 million shares, a stake valued at $1.57 billion as of June 30's close.

On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes ...

Eli Lilly & Co. raises Mounjaro prices in the United Kingdom to reduce costs in the U.S. Weight-loss drug prices increase by 170% in the U.K., but its National Health Service prices remained unchanged ...

It seems to be holding off on price adjustments demanded by President Trump.

Eli Lilly raised the price of its GLP-1, Zepbound, from about $125 to $165 and plans an additional hike next month that would almost double its price. In a note to clients Friday, Bank of America ...

Earlier today, it was announced that Precigen’s PAPZIMEOS (formerly PRGN-2012) was FDA-approved for adults with RRP. Read why ...

The integration aims to simplify access to Zepbound for eligible members while providing comprehensive, whole-person care to ...